Franklin Resources
TCON

Franklin Resources’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Franklin Resources’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,185
Closed -$115K – 2491
2022
Q1 		$115K Hold
2,185
– – ﹤0.01% 2273
2021
Q4 		$121K Hold
2,185
– – ﹤0.01% 2318
2021
Q3 		$169K Buy
+2,185
New +$185K ﹤0.01% 2262
2017
Q3 		– Sell
-2,266
Closed -$1.09M – 1522
2017
Q2 		$1.09M Sell
2,266
-2,082
-48% -$1.27M ﹤0.01% 1295
2017
Q1 		$3.26M Hold
4,348
– – ﹤0.01% 1171
2016
Q4 		$4.26M Buy
+4,348
New +$4.97M ﹤0.01% 1114

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Franklin Resources's TCON Position: Q2 2022 in Review

Franklin Resources sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2022, closing a stake of 2,185 shares — an estimated $115K sold.

Franklin Resources first reported a position in TCON in Q4 2016 and held it in 6 quarters. The position peaked at $4.26M in Q4 2016. 31 funds tracked by Wall St. Rank hold TCON as of Q2 2022.

  • Franklin Resources reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Franklin Resources sold 2,185 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $115K.
  • Franklin Resources first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
  • Franklin Resources's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $4.26M in Q4 2016.
  • 31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Franklin Resources's 13F filing for Q2 2022, filed 11 Aug 2022.